Editor-in-Chief & Deputy Editor 2019-2021

 

Editor-in-Chief:

Nicolas LANTHIER

 

Deputy Editor:

Tim VANUYTSEL

 

Sponsors & Partners



Acta Gastroenterologica Belgica is supported by grants from its major sponsors

 

Acta Gastroenterologica Belgica is supported by grants

from its major sponsors

Dr Falk Pharma

 

 

 

 

 

 

Acta Gastro-Enterologica Belgica is published in

partnership with the following national societies


 

 

 

 

 

SRBGE

 

Letters



Autoimmune hepatitis in a patient with thymectomy: the benefit of histology and MUM-1 immunostaining


Price: €10,00

To the Editor, A 61 years-old female patient, with a history of myaesthenia gravis since 1992, for which she underwent a thymectomy and is treated by pyridostigmine 60 mg once daily, was referred to our outpatient clinic by her general practioner for symptoms of nausea, lack of appetite and pyrosis. Abdominal clinical examination and upper gastrointestinal tract endoscopy were normal. [Product Details...]



Calcium polystyrene sulfonate-induced gastrointestinal tract necrosis and perforation


Price: €10,00

To the Editor, Hyperkalaemia is defined as a high serum potassium level requiring urgent and specific treatments to prevent life-threatening complications. Cation-exchange resin, such as calcium polystyrene sulfonate (CPS), promotes potassium excretion in the intestinal/colonic lumen and is a treatment of choice when less aggressive treatment is allowed (1). We herein present three cases of CPSinduced gastrointestinal tract necrosis or perforation. [Product Details...]



Coexistence of ampulla Vater tumor and Castleman’s disease: a rare case report


Price: €10,00

To the Editor, Castleman’s disease (CD), which is localized in the pancreatic region, is a rare clinical condition, and it is usually quite difficult to diagnose it and to distinguish it from pancreatic malignancies and pancreatic adenocarcinoma metastases. [Product Details...]



Cystotome assisted stent recanalization : an alternative way of regaining access to occluded metal biliary stents


Price: €10,00

To the Editor, Increased survival of patients with malignant biliary strictures can present endoscopic challenges over time, as local tumor progression or in-stent granulation tissue may hamper biliary access (1,2). A 63-year-old male was referred to our endoscopy department following an episode of cholangitis (bilirubin level 2.2, upper limit of normal 1.0 mg/dl). One year earlier, diagnosis of a metastatic cholangiocarcinoma (Klatskin type IIIa) was made. Following triple stenting in Y-shaped configuration, with the upper two SEMS (Self Expandable Metal Stents) in juxtaposition, chemotherapy was initiated. [Product Details...]



How will the welfare state cope with welfare diseases such as NASH?


Price: €10,00

To the Editor, Last year, it was stated in this journal that NonAlcoholic Fatty Liver Disease (NAFLD) is becoming the biggest cause of liver disease in western countries (1). NAFLD may gain importance as Non-Alcoholic Steatohepatitis (NASH), a specific and serious form of NAFLD, is on the rise. It is estimated that in Belgium 3-4% of the population are affected by NASH, and it is projected that the prevalence will double by 2030 (2). Currently, over 90 drugs are being developed to treat NASH. [Product Details...]


  • «« Start
  • « Prev
  • 1
  • Next »
  • End »»
Results 1 - 5 of 5